Synthesis and activity evaluation of a series of cholanamides as modulators of the liver X receptors
The Liver X receptors (LXRs) are members of the nuclear receptor family, that play fundamental roles in cholesterol transport, lipid metabolism and modulation of inflammatory responses. In recent years, the synthetic steroid N,N-dimethyl-3β-hydroxycholenamide (DMHCA) arised as a promising LXR ligand...
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | , , , , , |
| Formato: | Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
Elsevier Ltd
2018
|
| Acceso en línea: | Registro en Scopus DOI Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| Sumario: | The Liver X receptors (LXRs) are members of the nuclear receptor family, that play fundamental roles in cholesterol transport, lipid metabolism and modulation of inflammatory responses. In recent years, the synthetic steroid N,N-dimethyl-3β-hydroxycholenamide (DMHCA) arised as a promising LXR ligand. This compound was able to dissociate certain beneficial LXRs effects from those undesirable ones involved in triglyceride metabolism. Here, we synthetized a series of DMHCA analogues with different modifications in the steroidal nucleus involving the A/B ring fusion, that generate changes in the overall conformation of the steroid. The LXRα and LXRβ activity of these analogues was evaluated by using a luciferase reporter assay in BHK21 cells. Compounds were tested in both the agonist and antagonist modes. Results indicated that the agonist/antagonist profile is dependent on the steroid configuration at the A/B ring junction. Notably, in contrast to DMHCA, the amide derived from lithocholic acid (2) with an A/B cis configuration and its 6,19-epoxy analogue 4 behaved as LXRα selective agonists, while the 2,19-epoxy analogues with an A/B trans configuration were antagonists of both isoforms. The binding mode of the analogues to both LXR isoforms was assessed by using 50 ns molecular dynamics (MD) simulations. Results revealed conformational differences between LXRα- and LXRβ-ligand complexes, mainly in the hydrogen bonding network that involves the C-3 hydroxyl. Overall, these results indicate that the synthetized DMHCA analogues could be interesting candidates for a therapeutic modulation of the LXRs. © 2018 Elsevier Ltd |
|---|---|
| Bibliografía: | Gabbi, C., Warner, M., Gustafsson, J.A., Action mechanisms of Liver X Receptors (2014) Biochem Biophys Res Commun, 446, pp. 647-650 Jakobsson, T., Treuter, E., Gustafsson, J.A., Steffensen, K.R., Liver X receptor biology and pharmacology: new pathways, challenges and opportunities (2012) Trends Pharmacol Sci, 33, pp. 394-404 Tice, C.M., Noto, P.B., Fan, K.Y., Zhuang, L., Lala, D.S., Singh, S.B., The medicinal chemistry of liver X receptor (LXR) modulators (2014) J Med Chem, 57, pp. 7182-7205 Hong, C., Tontonoz, P., Liver X receptors in lipid metabolism: opportunities for drug discovery (2014) Nat Rev Drug Discov, 13, pp. 433-444 Im, S.S., Osborne, T.F., Liver x receptors in atherosclerosis and inflammation (2011) Circ Res, 108, pp. 996-1001 Viennois, E., Mouzat, K., Dufour, J., Morel, L., Lobaccaro, J.M., Baron, S., Selective liver X receptor modulators (SLiMs): what use in human health? (2012) Mol Cell Endocrinol, 351, pp. 129-141 Repa, J.J., Liang, G., Ou, J., Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta (2000) Genes Dev, 14, pp. 2819-2830 Phelan, C.A., Weaver, J.M., Steger, D.J., Selective partial agonism of liver X receptor alpha is related to differential corepressor recruitment (2008) Mol Endocrinol, 22, pp. 2241-2249 Torocsik, D., Szanto, A., Nagy, L., Oxysterol signaling links cholesterol metabolism and inflammation via the liver X receptor in macrophages (2009) Mol Aspects Med, 30, pp. 134-152 Zhao, C., Dahlman-Wright, K., Liver X receptor in cholesterol metabolism (2010) J Endocrinol, 204, pp. 233-240 Song, C., Liao, S., Cholestenoic acid is a naturally occurring ligand for liver X receptor alpha (2000) Endocrinology, 141, pp. 4180-4184 Quinet, E.M., Savio, D.A., Halpern, A.R., Chen, L., Miller, C.P., Nambi, P., Gene-selective modulation by a synthetic oxysterol ligand of the liver X receptor (2004) J Lipid Res, 45, pp. 1929-1942 Kratzer, A., Buchebner, M., Pfeifer, T., Synthetic LXR agonist attenuates plaque formation in apoE-/- mice without inducing liver steatosis and hypertriglyceridemia (2009) J Lipid Res, 50, pp. 312-326 Yu, S., Li, S., Henke, A., Dissociated sterol-based liver X receptor agonists as therapeutics for chronic inflammatory diseases (2016) FASEB J, 30, pp. 2570-2579 Alvarez, L.D., Dansey, M.V., Grinman, D.Y., Destabilization of the torsioned conformation of a ligand side chain inverts the LXRbeta activity (2015) Biochim Biophys Acta Mol Cell Biol Lip, 1851, pp. 1577-1586 Viktorsson, E.O., Gabrielsen, M., Kumarachandran, N., Regulation of liver X receptor target genes by 22-functionalized oxysterols. Synthesis, in silico and in vitro evaluations (2017) Steroids, 118, pp. 119-127 Peng, D., Hiipakka, R.A., Dai, Q., Antiatherosclerotic effects of a novel synthetic tissue-selective steroidal liver X receptor agonist in low-density lipoprotein receptor-deficient mice (2008) J Pharmacol Exp Ther, 327, pp. 332-342 Fu, J., Cheng, K., Zhang, Z.M., Fang, R.Q., Zhu, H.L., Synthesis, structure and structure-activity relationship analysis of caffeic acid amides as potential antimicrobials (2010) Eur J Med Chem, 45, pp. 2638-2643 Kumar, R.R., Haveli, S.D., Kagan, H.B., A mild one-pot method for conversion of various steroidal secondary alcohols into the corresponding olefins (2011) Synlett, 12, pp. 1709-1712 Eduardo, S.L., Ghini, A.A., Burton, G., Oxido-bridged neurosteroid analogues. Synthesis of 2,19-oxido-allopregnanolone (2003) ARKIVOC, pp. 468-476 Karaki, F., Ohgane, K., Dodo, K., Hashimoto, Y., Structure-activity relationship studies of Niemann-Pick type C1-like 1 (NPC1L1) ligands identified by screening assay monitoring pharmacological chaperone effect (2013) Bioorg Med Chem, 21, pp. 5297-5309 Truss, M., Bartsch, J., Schelbert, A., Hache, R.J., Beato, M., Hormone induces binding of receptors and transcription factors to a rearranged nucleosome on the MMTV promoter in vivo (1995) EMBO J, 14, pp. 1737-1751 Sali, A., Blundell, T.L., Comparative protein modelling by satisfaction of spatial restraints (1993) J Mol Biol, 234, pp. 779-815 Frisch, M.J., Schlegel, H.B., Scuseria, G.E., Gaussian 09 (2009), Gaussian Inc Wallingford, CT, USA; Case, D.A., Betz, R.M., Cerutti, D.S., AMBER 2015 (2015), University of California San Francisco; Roe, D.R., Cheatham, T.E., 3rd., PTRAJ and CPPTRAJ: software for processing and analysis of molecular dynamics trajectory data (2013) J Chem Theory Comput, 9, pp. 3084-3095 Humphrey, W., Dalke, A., Schulten, K., VMD: visual molecular dynamics (1996) J Mol Graph, 14, pp. 27-38 |
| ISSN: | 09680896 |
| DOI: | 10.1016/j.bmc.2018.01.025 |